← FDA Drug Approvals (Drugs@FDA)
PALIPERIDONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ESKAYEF · Approved 2025-09-04
Drug application
- FDA Application #
ANDA218755- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- PALIPERIDONE
- Generic name
- PALIPERIDONE
- Active ingredients
- PALIPERIDONE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ESKAYEF
- Manufacturer
- Eskayef Pharmaceuticals Limited
- First approval
- 2025-09-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown